CA
NZ
UK
AU
IND
US
Avantor, Inc. disclosed on July 17, 2026, that its subsidiary Avantor Funding, Inc. has refinanced a portion of its senior secured euro-denominated debt through Amendment No. 15 to its existing Credit Agreement. The company obtained €374.2 million in new Incremental B-7 Euro Term Loans …
Southern Copper Corporation held its 2026 Annual Meeting of Stockholders on May 29, 2026, with strong shareholder participation. The company's stockholders elected eight directors to serve until the 2027 annual meeting, ratified the appointment of Galaz, Yamazaki, Ruiz Urquiza S.C. as independent auditors for …
Morgan Stanley has announced the issuance of Fixed Rate Notes due 2032, carrying a fixed interest rate of 4.9% per annum payable semi-annually. The preliminary pricing supplement, filed on July 17, 2026, outlines the terms for debt securities with a stated principal amount of …
Florian Baumgartner, Executive Vice President and Chief Executive Officer of Vista at Cimpress plc (NASDAQ: CMPR), received a restricted share unit award on July 15, 2026, according to a regulatory update filed with the Securities and Exchange Commission. The transaction involved the acquisition of …
Clorox Company (NYSE: CLX) disclosed that Chris T. Hyder, Executive Vice President and Chief Operating Officer, completed a stock transaction on July 15, 2026, involving the acquisition and disposition of common shares. The transaction reflects routine equity management activity by a senior executive of …
Alec C. Covington, a director of QXO, Inc., has received 25 additional shares of common stock and 9,639 restricted stock units following the finalization of merger calculations with TopBuild Corp. The update, disclosed in a regulatory filing dated July 17, 2026, reflects adjustments to …
Terry L. Riesterer, Vice President and Controller at Rockwell Automation, Inc., disclosed equity transactions on July 16, 2026, involving the acquisition of restricted stock units that vested and a subsequent sale of common shares. The transactions, executed under a pre-established Rule 10b5-1 trading plan …
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) disclosed that Brian Elsbernd, the company's Chief Legal Officer, disposed of 242,501 shares of common stock on July 15, 2026, at $31.50 per share in connection with the consummation of the company's acquisition by Angelini Pharma S.p.A. The transaction …
Mark A. Crosswhite, a director at Regions Financial Corporation, acquired 992.6938 shares of phantom stock on July 15, 2026, as part of the bank's Director Compensation Program. The transaction reflects Crosswhite's election to receive deferred compensation in phantom stock form rather than cash, bringing …
Regions Financial Corporation director Lee J. Styslinger III acquired 992.6938 shares of phantom stock on July 15, 2026, as part of the company's Director Compensation Program. The transaction, disclosed in a regulatory update filed July 17, 2026, reflects Styslinger's election to receive deferred compensation …
Please wait processing your request...